Lonza Consolidates its Custom Manufacturing Businesses

Lonza says it has combined its Exclusive Synthesis and Biopharmaceutical business sectors into a single division called Lonza Custom Manufacturing. These changes are effective from today and the new merged division will be jointly led by Stephan Kutzer, head of the Biopharmaceuticals business sector and Uwe H. Boehlke, head of the Exclusive Synthesis...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers